Each capsule contains:
- 150 mg of dried iron sulfate
- 0.5 mg of folic acid
- 10 μg of cyanocobalamin
- 100 mg of ascorbic acid.
Excipients: dibasic calcium phosphate, purified talc, starch, polyvinyl pyrolidone, white beeswax, glyceryl monosterate, polyethylene glycol 6000.
Fersinol is a complex antianemic drug containing ferrous iron in the form of a simple salt of ferrous sulfate, vitamin B12, folic and ascorbic acid, intended for the treatment of iron deficiency conditions.
Iron sulfate, which is part of Fersinol, compensates for the iron deficiency in the body. It is found in hemoglobin, myoglobin, and various other enzymes. As a structural component of heme, it takes part in erythropoiesis.
Ascorbic acid improves intestinal iron absorption. Vitamin B12 and folic acid are involved in the formation and maturation of red blood cells.
The active components of the drug Fersinol are in a special neutral shell, which ensures their absorption, mainly from the upper part of the small intestine. The absence of local irritating effect on the gastric mucosa contributes to the good tolerance of Fersinol from the gastrointestinal tract.
• Treatment of anemias caused by concomitant deficiency of iron, folic acid and vitamin B12, arising against the background of chronic blood loss (gastrointestinal bleeding, bleeding from the bladder, bleeding from hemorrhoids, meno- and metrorrhagia), as well as against the background of chronic alcoholism, infectious diseases, taking anticonvulsants and oral contraceptives;
• Treatment of anemias during pregnancy and lactation;
• Prevention of iron and folic acid deficiency in the II and III trimesters of pregnancy, in the postpartum period, during lactation.
• Anemias not associated with iron deficiency (hemolytic anemia, megaloblastic anemia associated with isolated vitamin B12 deficiency);
• Increased iron content in the body (hemosiderosis);
• Violation of the mechanisms of iron utilization (anemia caused by lead poisoning, sideroachrestic anemia).
From the digestive system: rarely – epigastric pain, diarrhea, constipation.
Others: in some cases – allergic reactions.
Pregnancy and lactation:
Fersinol is prescribed during pregnancy and lactation as prescribed.
During the period of taking the drug Fersinol, dark staining of the stool may be observed, which is due to the elimination of non-absorbed iron and has no clinical significance.
Symptoms: epigastric pain, nausea, vomiting, diarrhea, drowsiness, pallor of the skin.
Treatment: gastric lavage, symptomatic therapy. The antidote is desferroxamine.
Interaction with other medicinal products:
Organic acids, calcium salts, phosphates, phytin, cholestyramine, as well as antacids containing aluminum, magnesium, calcium interfere with the absorption of iron due to the formation of insoluble complexes.
Iron salts interfere with the absorption of antibiotics of the tetracycline group in the gastrointestinal tract.
Preparations containing pancreatic enzymes can reduce iron absorption.
With the simultaneous use of the drug Fersinol with phenobarbital, carbamazepine, sodium valproate, sulfasalazine, hormonal contraceptives, folic acid antagonists, trimethoprim, pyrimethamine, triamethrene, the absorption of folic acid decreases.
With a mild course of anemia, Fersinol is prescribed 1 caps. 1-2 times / day for 3-4 weeks; with moderate anemia – 1 caps. 1-2 times / day for 8-12 weeks; in severe anemia – 2 caps. 2 times / day for 16 weeks or more. For the prevention of iron and folic acid deficiency during pregnancy and lactation, Fersinol is prescribed 1 capsule. 2 times / day in the II and III trimesters and in the postpartum period during breastfeeding.
Fersinol capsules should be taken after meals.
Store at a temperature not exceeding 25°C.
Keep out of the reach of children